EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy-Related Hypophysitis: A Narrative Review

Vincenza Di Stasi, Domenico La Sala, Renato Cozzi, Francesco Scavuzzo, Vincenzo De Geronimo iD, Maurizio Poggi, Mario Vitale, Anna Tortora

Cancers · 27.01.2025 · 17 (3) · 436

DOI: 10.3390/cancers17030436 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.01.2025. Verfasst von Vincenza Di Stasi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroentherology IRCCS Saverio De Bellis,…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have revolutionized oncology, providing a groundbreaking therapeutic option for patients with various advanced-stage cancers. While these treatments can significantly extend survival, they also carry a substantial risk of immune-related adverse events, among which hypophysitis is particularly detrimental to endocrine function. This narrative review synthesizes current knowledge on the pathogenesis, clinical features, diagnosis, and management of ICI-induced hypophysitis (IH) based on an in-depth analysis of the recent literature and clinical trials. The diagnosis of IH presents unique challenges due to its overlap with systemic symptoms commonly associated with the underlying malignancy. These symptoms can include asthenia, anorexia, headache, vomiting, weight loss, hypotension, dizziness, decreased libido, and visual disturbances. Diagnostic evaluation typically combines clinical assessment, hormonal profiling, and findings from magnetic resonance imaging (MRI). Effective management of IH requires a personalized, multidisciplinary approach, focusing on hormone replacement therapy and vigilant monitoring. Long-term care depends on the severity of hypophysitis, and the specific hormonal axes involved. This review aims to enhance awareness of the critical aspects of recognizing and managing IH, underscoring the importance of early diagnosis and timely intervention to reduce its long-term effects on patient quality of life.

Schlagwörter

Stichwörter der Autor:innen

hypophysitisimmune checkpoint inhibitorsimmunotherapy

Autor:innen und Institutionen

  • Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroentherology IRCCS Saverio De Bellis, 70013 Castellana Grotte, Italy.
  • UOSD Malattie Endocrine Nutrizione e Ricambio, AORN, San Giuseppe Moscati, 83100 Avellino, Italy.
  • Endocrine Unit Grande Ospedale Metropolitano, Niguarda, 20162 Milano, Italy.
  • UOC Endocrinologia AORN A. Cardarelli, 80131 Napoli, Italy.
  • Centro Clinico Diagnostico GB Morgagni srl, 95125 Catania, Italy.
  • UOC Medicina Specialistica Endocrino-Metabolica, AOU Sant'Andrea, 00189 Roma, Italy.

ORCID-Profile: Vincenzo De Geronimo

Zitieren

APA

Di Stasi, V., La Sala, D., Cozzi, R., Scavuzzo, F., De Geronimo, V., Poggi, M., Vitale, M., & Tortora, A. (2025). Immunotherapy-Related Hypophysitis: A Narrative Review. Cancers, 17(3), 436. https://doi.org/10.3390/cancers17030436

Vancouver

Di Stasi V, La Sala D, Cozzi R, Scavuzzo F, De Geronimo V, Poggi M, et al. Immunotherapy-Related Hypophysitis: A Narrative Review. Cancers. 2025;17(3):436. doi:10.3390/cancers17030436

BibTeX
@article{DiStasi2025,
  author = {Di Stasi, Vincenza and La Sala, Domenico and Cozzi, Renato and Scavuzzo, Francesco and De Geronimo, Vincenzo and Poggi, Maurizio and Vitale, Mario and Tortora, Anna},
  title = {Immunotherapy-Related Hypophysitis: A Narrative Review},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {436},
  doi = {10.3390/cancers17030436}
}
Kostenlos starten →